{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:31:18Z","timestamp":1780504278435,"version":"3.54.1"},"reference-count":129,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OVS"],"published-print":{"date-parts":[[2008,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>In recent years the focus of glaucoma research has shifted toward neuroprotection, as the traditional strategies of lowering intraocular pressure have been shown to be unable to prevent progressive vision loss in some glaucoma patients. As a result various neuroprotective drug\u2010based approaches have been shown capable of reducing the death of retinal ganglion cells, which is the hallmark of glaucomatous optic neuropathy. There has been increasing evidence that glaucomatous neurodegeneration is analogous to other neurodegenerative diseases in the central nervous system, with recent work from our group elucidating a strong link between basic cellular processes in glaucoma and Alzheimer's disease. Additionally, there is a growing trend for using existing neuroprotective strategies in central nervous system diseases for the treatment of glaucoma. In fact, a trial treating patients with primary open\u2010angle glaucoma with memantine, a drug approved for the treatment of Alzheimer's disease, has recently been completed. Results of this trial are not yet available. In this review, we will examine currently advocated neuroprotective drug\u2010based strategies in the potential management of glaucoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/opx.0b013e31817841e5","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T13:59:53Z","timestamp":1212587993000},"source":"Crossref","is-referenced-by-count":82,"title":["Neuroprotection in Glaucoma: Drug\u2010Based Approaches"],"prefix":"10.1002","volume":"85","author":[{"given":"WILLIAM","family":"CHEUNG","sequence":"first","affiliation":[{"name":"Glaucoma &amp; Retinal Degeneration Research Group UCL Institute of Ophthalmology London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LI","family":"GUO","sequence":"additional","affiliation":[{"name":"Glaucoma &amp; Retinal Degeneration Research Group UCL Institute of Ophthalmology London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M FRANCESCA","family":"CORDEIRO","sequence":"additional","affiliation":[{"name":"Glaucoma &amp; Retinal Degeneration Research Group UCL Institute of Ophthalmology London United Kingdom"},{"name":"The Glaucoma Research Group, Western Eye Hospital London United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,1]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"crossref","first-page":"13352","DOI":"10.1073\/pnas.0405479101","article-title":"Real\u2010time imaging of single nerve cell apoptosis in retinal neurodegeneration","volume":"101","author":"Cordeiro MF","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_3_2","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/bjo.80.5.389","article-title":"Number of people with glaucoma worldwide","volume":"80","author":"Quigley HA","year":"1996","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"e_1_2_4_4_2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0039-6257(03)00007-9","article-title":"Retinal ganglion cells and neuroprotection for glaucoma","volume":"48","author":"Levin LA","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_4_5_2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3129\/i07-075","article-title":"Is this neuroprotective drug good for my glaucoma patients? Some key factors in clinical decision\u2010making","volume":"42","author":"Goldberg I","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"e_1_2_4_6_2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00055735-200204000-00002","article-title":"Current understanding of neuroprotection in glaucoma","volume":"13","author":"Wein FB","year":"2002","journal-title":"Curr Opin Ophthalmol"},{"key":"e_1_2_4_7_2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3129\/i07-045","article-title":"Glaucoma neuroprotection: what is it? why is it needed?","volume":"42","author":"Weinreb RN","year":"2007","journal-title":"Can J Ophthalmol"},{"key":"e_1_2_4_8_2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archopht.121.1.48","article-title":"Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial","volume":"121","author":"Leske MC","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_4_9_2","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0002-9394(03)00478-1","article-title":"Factors that predict the benefit of lowering intraocular pressure in normal tension glaucoma","volume":"136","author":"Anderson DR","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_4_10_2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0002-9394(98)00223-2","article-title":"Comparison of glaucomatous progression between untreated patients with normal\u2010tension glaucoma and patients with therapeutically reduced intraocular pressures","volume":"126","author":"Collaborative Normal\u2010Tension Glaucoma Study Group","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_4_11_2","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-200767050-00006","article-title":"Pharmacological neuroprotection for glaucoma","volume":"67","author":"Chidlow G","year":"2007","journal-title":"Drugs"},{"key":"e_1_2_4_12_2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0006-8993(02)03731-9","article-title":"Neuroprotection by memantine against neurodegeneration induced by beta\u2010amyloid(1\u201340)","volume":"958","author":"Miguel\u2010Hidalgo JJ","year":"2002","journal-title":"Brain Res"},{"key":"e_1_2_4_13_2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0149-2918(04)90064-1","article-title":"Pharmacotherapeutic approaches to the treatment of Alzheimer\u2019s disease","volume":"26","author":"Standridge JB","year":"2004","journal-title":"Clin Ther"},{"key":"e_1_2_4_14_2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1567205043332063","article-title":"Acetylcholinesterase (AChE)\u2013amyloid\u2010beta\u2010peptide complexes in Alzheimer\u2019s disease. The Wnt signaling pathway","volume":"1","author":"Inestrosa NC","year":"2004","journal-title":"Curr Alzheimer Res"},{"key":"e_1_2_4_15_2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s11064-006-9203-y","article-title":"Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes","volume":"32","author":"Calabrese V","year":"2007","journal-title":"Neurochem Res"},{"key":"e_1_2_4_16_2","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.0703707104","article-title":"Targeting amyloid\u2010beta in glaucoma treatment","volume":"104","author":"Guo L","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_17_2","first-page":"712","article-title":"Retinal ganglion cells, glaucoma and neuroprotection","volume":"131","author":"Lipton SA","year":"2001","journal-title":"Prog Brain Res"},{"key":"e_1_2_4_18_2","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1167\/iovs.03-0567","article-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures","volume":"45","author":"Hare WA","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_19_2","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1167\/iovs.03-0566","article-title":"Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures","volume":"45","author":"Hare WA","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_20_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/01.ijg.0000146372.74366.e4","article-title":"Memantine and progressive glaucoma","volume":"14","author":"Greenfield DS","year":"2005","journal-title":"J Glaucoma"},{"key":"e_1_2_4_21_2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archopht.124.2.217","article-title":"Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma","volume":"124","author":"Yucel YH","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_4_22_2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/02713680701585872","article-title":"Assessment of rat and mouse RGC apoptosis imaging in vivo with different scanning laser ophthalmoscopes","volume":"32","author":"Maass A","year":"2007","journal-title":"Curr Eye Res"},{"key":"e_1_2_4_23_2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1167\/iovs.05-0754","article-title":"Assessment of neuroprotective effects of glutamate modulation on glaucoma\u2010related retinal ganglion cell apoptosis in vivo","volume":"47","author":"Guo L","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"e_1_2_4_24_2","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/S0039-6257(99)00044-2","article-title":"Neuroprotection in relation to retinal ischemia and relevance to glaucoma","volume":"43","author":"Osborne NN","year":"1999","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_4_25_2","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/sj.eye.6701967","article-title":"Glutamate excitotoxicity in glaucoma: throwing the baby out with the bathwater?","volume":"20","author":"Salt TE","year":"2006","journal-title":"Eye"},{"key":"e_1_2_4_26_2","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0006-8993(98)00212-1","article-title":"MK801\u2010a neuroprotectant in rat hypertensive eyes","volume":"792","author":"Chaudhary P","year":"1998","journal-title":"Brain Res"},{"key":"e_1_2_4_27_2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/00061198-200212000-00003","article-title":"Neuroprotective effect of memantine in different retinal injury models in rats","volume":"11","author":"WoldeMussie E","year":"2002","journal-title":"J Glaucoma"},{"key":"e_1_2_4_28_2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/archopht.1996.01100130295012","article-title":"Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma","volume":"114","author":"Dreyer EB","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_4_29_2","doi-asserted-by":"crossref","first-page":"864","DOI":"10.2460\/ajvr.1997.58.08.864","article-title":"Vitreous body glutamate concentration in dogs with glaucoma","volume":"58","author":"Brooks DE","year":"1997","journal-title":"Am J Vet Res"},{"key":"e_1_2_4_30_2","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S1350-9462(01)00022-2","article-title":"Visual field defects and neural losses from experimental glaucoma","volume":"21","author":"Harwerth RS","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"e_1_2_4_31_2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archopht.121.2.183","article-title":"Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy","volume":"121","author":"Honkanen RA","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_4_32_2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/00061198-200210000-00005","article-title":"Measurement of amino acid levels in the vitreous humor of rats after chronic intraocular pressure elevation or optic nerve transection","volume":"11","author":"Levkovitch\u2010Verbin H","year":"2002","journal-title":"J Glaucoma"},{"key":"e_1_2_4_33_2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archopht.123.1.64","article-title":"Vitreous glutamate concentration and axon loss in monkeys with experimental glaucoma","volume":"123","author":"Wamsley S","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_4_34_2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.1957.00940010205006","article-title":"The toxic effect of sodium l\u2010glutamate on the inner layers of the retina","volume":"58","author":"Lucas DR","year":"1957","journal-title":"AMA Arch Ophthalmol"},{"key":"e_1_2_4_35_2","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1097\/00005072-196907000-00007","article-title":"Glutaate\u2010induced retinal degeneration in neonatal mice. Electron microscopy of the acutely evolving lesion","volume":"28","author":"Olney JW","year":"1969","journal-title":"J Neuropathol Exp Neurol"},{"key":"e_1_2_4_36_2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/227609b0","article-title":"Brain damage in infant mice following oral intake of glutamate, aspartate or cysteine","volume":"227","author":"Olney JW","year":"1970","journal-title":"Nature"},{"key":"e_1_2_4_37_2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton SA","year":"1994","journal-title":"N Engl J Med"},{"key":"e_1_2_4_38_2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0143-4160(98)90115-4","article-title":"Calcium, free radicals and excitotoxins in neuronal apoptosis","volume":"23","author":"Lipton SA","year":"1998","journal-title":"Cell Calcium"},{"key":"e_1_2_4_39_2","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0896-6273(88)90162-6","article-title":"Glutamate neurotoxicity and diseases of the nervous system","volume":"1","author":"Choi DW","year":"1988","journal-title":"Neuron"},{"key":"e_1_2_4_40_2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0165-6147(90)90184-A","article-title":"Excitatory amino acid neurotoxicity and neurodegenerative disease","volume":"11","author":"Meldrum B","year":"1990","journal-title":"Trends Pharmacol Sci"},{"key":"e_1_2_4_41_2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/(SICI)1096-9861(20000424)420:1<98::AID-CNE7>3.0.CO;2-U","article-title":"Synaptic localization of NMDA receptor subunits in the rat retina","volume":"420","author":"Fletcher EL","year":"2000","journal-title":"J Comp Neurol"},{"key":"e_1_2_4_42_2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/325529a0","article-title":"Glycine potentiates the NMDA response in cultured mouse brain neurons","volume":"325","author":"Johnson JW","year":"1987","journal-title":"Nature"},{"key":"e_1_2_4_43_2","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1046\/j.1471-4159.1998.71030946.x","article-title":"Role of caspases in N\u2010methyl\u2010d\u2010aspartate\u2010induced apoptosis in cerebrocortical neurons","volume":"71","author":"Tenneti L","year":"1998","journal-title":"J Neurochem"},{"key":"e_1_2_4_44_2","doi-asserted-by":"crossref","first-page":"6161","DOI":"10.1073\/pnas.100121097","article-title":"Mitochondrial and extramitochondrial apoptotic signaling pathways in cerebrocortical neurons","volume":"97","author":"Budd SL","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_45_2","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1073\/pnas.022036399","article-title":"Dominant\u2010interfering forms of MEF2 generated by caspase cleavage contribute to NMDA\u2010induced neuronal apoptosis","volume":"99","author":"Okamoto S","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_46_2","doi-asserted-by":"crossref","first-page":"10963","DOI":"10.1523\/JNEUROSCI.3461-04.2004","article-title":"Apoptosis\u2010inducing factor substitutes for caspase executioners in NMDA\u2010triggered excitotoxic neuronal death","volume":"24","author":"Wang H","year":"2004","journal-title":"J Neurosci"},{"key":"e_1_2_4_47_2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1385\/MN:34:3:163","article-title":"N\u2010methyl\u2010D\u2010aspartate receptors in the retina","volume":"34","author":"Shen Y","year":"2006","journal-title":"Mol Neurobiol"},{"key":"e_1_2_4_48_2","first-page":"1096","article-title":"Selective excitotoxic degeneration of adult pig retinal ganglion cells in vitro","volume":"42","author":"Luo X","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_49_2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/cne.10830","article-title":"Inner retinal neurons display differential responses to N\u2010methyl\u2010d\u2010aspartate receptor activation","volume":"465","author":"Sun D","year":"2003","journal-title":"J Comp Neurol"},{"key":"e_1_2_4_50_2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/j.1460-9568.1994.tb00607.x","article-title":"Expression of NMDA and high\u2010affinity kainate receptor subunit mRNAs in the adult rat retina","volume":"6","author":"Brandstatter JH","year":"1994","journal-title":"Eur J Neurosci"},{"key":"e_1_2_4_51_2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuint.2007.04.026","article-title":"Excitotoxic mechanisms in stroke: an update of concepts and treatment strategies","volume":"50","author":"Hazell AS","year":"2007","journal-title":"Neurochem Int"},{"key":"e_1_2_4_52_2","first-page":"2236","article-title":"Retinal glutamate transporter changes in experimental glaucoma and after optic nerve transection in the rat","volume":"43","author":"Martin KR","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_53_2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/glia.20000","article-title":"Muller cell response to laser\u2010induced increase in intraocular pressure in rats","volume":"47","author":"Woldemussie E","year":"2004","journal-title":"Glia"},{"key":"e_1_2_4_54_2","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1167\/iovs.06-0231","article-title":"Evoked expression of the glutamate transporter GLT\u20101c in retinal ganglion cells in human glaucoma and in a rat model","volume":"47","author":"Sullivan RK","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_55_2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1126\/science.2660263","article-title":"Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs","volume":"244","author":"Olney JW","year":"1989","journal-title":"Science"},{"key":"e_1_2_4_56_2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1006\/exnr.1993.1153","article-title":"Neuronal vacuolization and necrosis induced by the noncompetitive N\u2010methyl\u2010d\u2010aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex","volume":"123","author":"Fix AS","year":"1993","journal-title":"Exp Neurol"},{"key":"e_1_2_4_57_2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(93)90198-U","article-title":"Prospects for clinically tolerated NMDA antagonists: open\u2010channel blockers and alternative redox states of nitric oxide","volume":"16","author":"Lipton SA","year":"1993","journal-title":"Trends Neurosci"},{"key":"e_1_2_4_58_2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1055\/s-2008-1069311","article-title":"[Effects of oral memantine administration on Parkinson symptoms. Results of a placebo\u2010controlled multicenter study]","volume":"109","author":"Schneider E","year":"1984","journal-title":"Dtsch Med Wochenschr"},{"key":"e_1_2_4_59_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF02260076","article-title":"Efficacy of memantine, an NMDA receptor antagonist, in the treatment of Parkinson\u2019s disease","volume":"4","author":"Rabey JM","year":"1992","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"e_1_2_4_60_2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00004850-200211000-00005","article-title":"A double\u2010blind, placebo\u2010controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)","volume":"17","author":"Wilcock G","year":"2002","journal-title":"Int Clin Psychopharmacol"},{"key":"e_1_2_4_61_2","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1161\/01.STR.0000020094.08790.49","article-title":"Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo\u2010controlled trial (MMM 300)","volume":"33","author":"Orgogozo JM","year":"2002","journal-title":"Stroke"},{"key":"e_1_2_4_62_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0014-2999(89)90385-3","article-title":"Memantine is a potent blocker of N\u2010methyl\u2010D\u2010aspartate (NMDA) receptor channels","volume":"166","author":"Bormann J","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"e_1_2_4_63_2","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen HS","year":"2006","journal-title":"J Neurochem"},{"key":"e_1_2_4_64_2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.febslet.2004.04.047","article-title":"Memantine inhibits and reverses the Alzheimer type abnormal hyperphosphorylation of tau and associated neurodegeneration","volume":"566","author":"Li L","year":"2004","journal-title":"FEBS Lett"},{"key":"e_1_2_4_65_2","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Open\u2010channel block of N\u2010methyl\u2010d\u2010aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor\u2010mediated neurotoxicity","volume":"12","author":"Chen HS","year":"1992","journal-title":"J Neurosci"},{"key":"e_1_2_4_66_2","first-page":"22","article-title":"NMDA receptor antagonists. A new therapeutic approach for Alzheimer\u2019s disease","volume":"59","author":"Farlow MR","year":"2004","journal-title":"Geriatrics"},{"issue":"1","key":"e_1_2_4_67_2","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0039-6257(03)00008-0","article-title":"Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage","volume":"48","author":"Lipton SA","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_4_68_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3341\/kjo.2002.16.1.1","article-title":"Neuroprotective effect of memantine in a rabbit model of optic nerve ischemia","volume":"16","author":"Kim TW","year":"2002","journal-title":"Korean J Ophthalmol"},{"key":"e_1_2_4_69_2","first-page":"1063","article-title":"Memantine is neuroprotective in a rat model of pressure\u2010induced retinal ischemia","volume":"39","author":"Lagreze WA","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_70_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1017\/S0952523899161017","article-title":"Memantine reduces alterations to the mammalian retina, in situ, induced by ischemia","volume":"16","author":"Osborne NN","year":"1999","journal-title":"Vis Neurosci"},{"key":"e_1_2_4_71_2","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/S0042-6989(02)00188-8","article-title":"Effects of anti\u2010glaucoma medications on ganglion cell survival: the DBA\/2J mouse model","volume":"42","author":"Schuettauf F","year":"2002","journal-title":"Vision Res"},{"key":"e_1_2_4_72_2","first-page":"3451","article-title":"Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model","volume":"41","author":"Mittag TW","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"e_1_2_4_73_2","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.1016\/S0039-6257(01)00207-7","article-title":"Maintaining mitochondrial membrane impermeability. an opportunity for new therapy in glaucoma?","volume":"45","author":"Tatton WG","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_4_74_2","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1167\/iovs.04-0490","article-title":"Caspase\u2010independent component of retinal ganglion cell death, in vitro","volume":"45","author":"Tezel G","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_75_2","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1167\/iovs.05-1639","article-title":"Mitochondrial abnormalities in patients with primary open\u2010angle glaucoma","volume":"47","author":"Abu\u2010Amero KK","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_76_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.taap.2004.04.019","article-title":"Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water\u2010soluble Coenzyme Q10","volume":"201","author":"McCarthy S","year":"2004","journal-title":"Toxicol Appl Pharmacol"},{"key":"e_1_2_4_77_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli V","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"e_1_2_4_78_2","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.18.1.621","article-title":"Phosphorylation meets ubiquitination: the control of NF\u2010\u03baB activity","volume":"18","author":"Karin M","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"e_1_2_4_79_2","doi-asserted-by":"crossref","first-page":"38415","DOI":"10.1074\/jbc.M404928200","article-title":"Recruitment of NF\u2010kappaB into mitochondria is involved in adenine nucleotide translocase 1\u2010induced apoptosis","volume":"279","author":"Zamora M","year":"2004","journal-title":"J Biol Chem"},{"key":"e_1_2_4_80_2","doi-asserted-by":"crossref","first-page":"28220","DOI":"10.1074\/jbc.M302297200","article-title":"Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property","volume":"278","author":"Papucci L","year":"2003","journal-title":"J Biol Chem"},{"key":"e_1_2_4_81_2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0074-7742(07)82022-8","article-title":"Retinal damage caused by high intraocular pressure\u2010induced transient ischemia is prevented by coenzyme Q10 in rat","volume":"82","author":"Nucci C","year":"2007","journal-title":"Int Rev Neurobiol"},{"key":"e_1_2_4_82_2","article-title":"Topical CoQ10 is neuroprotective in experimental glaucoma[abstract]","volume":"48","author":"Cordeiro MF","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_83_2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.med.57.121304.131243","article-title":"Amyloidosis","volume":"57","author":"Pepys MB","year":"2006","journal-title":"Annu Rev Med"},{"key":"e_1_2_4_84_2","first-page":"1077","article-title":"Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension","volume":"43","author":"McKinnon SJ","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_85_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s10384-004-0156-x","article-title":"Vitreous fluid levels of beta\u2010amyloid((1\u201342)) and tau in patients with retinal diseases","volume":"49","author":"Yoneda S","year":"2005","journal-title":"Jpn J Ophthalmol"},{"key":"e_1_2_4_86_2","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/S1388-2457(01)00620-4","article-title":"Morphological and functional retinal impairment in Alzheimer\u2019s disease patients","volume":"112","author":"Parisi V","year":"2001","journal-title":"Clin Neurophysiol"},{"key":"e_1_2_4_87_2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","article-title":"Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease","volume":"26","author":"Iseri PK","year":"2006","journal-title":"J Neuroophthalmol"},{"key":"e_1_2_4_88_2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0197-4580(96)00009-7","article-title":"Retinal pathology in Alzheimer\u2019s disease. II. Regional neuron loss and glial changes in GCL","volume":"17","author":"Blanks JC","year":"1996","journal-title":"Neurobiol Aging"},{"key":"e_1_2_4_89_2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0197-4580(96)00010-3","article-title":"Retinal pathology in Alzheimer\u2019s disease. I. Ganglion cell loss in foveal\/parafoveal retina","volume":"17","author":"Blanks JC","year":"1996","journal-title":"Neurobiol Aging"},{"key":"e_1_2_4_90_2","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0002-9394(01)01196-5","article-title":"Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer\u2019s disease and Parkinson\u2019s disease","volume":"133","author":"Bayer AU","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_4_91_2","doi-asserted-by":"crossref","first-page":"11830","DOI":"10.1073\/pnas.192203399","article-title":"The Alzheimer\u2019s A beta\u2010peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age\u2010related macular degeneration","volume":"99","author":"Johnson LV","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_92_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.mehy.2004.01.013","article-title":"Can chronic increased intracranial pressure or exposure to repetitive intermittent intracranial pressure elevations raise your risk for Alzheimer\u2019s disease?","volume":"62","author":"Wostyn P","year":"2004","journal-title":"Med Hypotheses"},{"key":"e_1_2_4_93_2","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1097\/00001756-199806220-00026","article-title":"Expression and localization in the fish retina of a homologue of the Alzheimer\u2019s related PS1 gene","volume":"9","author":"Archer S","year":"1998","journal-title":"Neuroreport"},{"key":"e_1_2_4_94_2","first-page":"24","article-title":"Immunoreactivity against tau, amyloid precursor protein, and beta\u2010amyloid in the human retina","volume":"36","author":"Loffler KU","year":"1995","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_95_2","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1006\/exnr.1995.1104","article-title":"Intraperikaryal neurofilamentous accumulations in a subset of retinal ganglion cells in aged mice that express a human neurofilament gene","volume":"136","author":"Vickers JC","year":"1995","journal-title":"Exp Neurol"},{"key":"e_1_2_4_96_2","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archopht.118.4.511","article-title":"Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes","volume":"118","author":"Tezel G","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"e_1_2_4_97_2","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1167\/iovs.02-0912","article-title":"Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model","volume":"44","author":"Ishii Y","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_98_2","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.neulet.2005.11.065","article-title":"Geranylgeranylacetone, a noninvasive heat shock protein inducer, induces protein kinase C and leads to neuroprotection against cerebral infarction in rats","volume":"396","author":"Uchida S","year":"2006","journal-title":"Neurosci Lett"},{"key":"e_1_2_4_99_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mrrev.2005.11.001","article-title":"The role of oxidative stress in glaucoma","volume":"612","author":"Izzotti A","year":"2006","journal-title":"Mutat Res"},{"key":"e_1_2_4_100_2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S1350-9462(03)00064-8","article-title":"The effects of antiglaucoma and systemic medications on ocular blood flow","volume":"22","author":"Costa VP","year":"2003","journal-title":"Prog Retin Eye Res"},{"key":"e_1_2_4_101_2","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S1350-9462(02)00008-3","article-title":"The impact of ocular blood flow in glaucoma","volume":"21","author":"Flammer J","year":"2002","journal-title":"Prog Retin Eye Res"},{"key":"e_1_2_4_102_2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.freeradbiomed.2005.03.025","article-title":"Dynamic changes in reactive oxygen species and antioxidant levels in retinas in experimental glaucoma","volume":"39","author":"Ko ML","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"e_1_2_4_103_2","first-page":"13","article-title":"[Lipid peroxidation in the blood of primary glaucoma patients]","volume":"102","author":"Birich TV","year":"1986","journal-title":"Vestn Oftalmol"},{"key":"e_1_2_4_104_2","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0002-9394(03)00788-8","article-title":"Oxidative stress markers in aqueous humor of glaucoma patients","volume":"137","author":"Ferreira SM","year":"2004","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_4_105_2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1167\/iovs.04-0777","article-title":"Systemic reduction in glutathione levels occurs in patients with primary open\u2010angle glaucoma","volume":"46","author":"Gherghel D","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_106_2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pathophys.2004.08.001","article-title":"Antioxidant effects of alpha\u2010, gamma\u2010and succinate\u2010tocopherols in guinea pig retina during ischemia\u2010reperfusion injury","volume":"11","author":"Aydemir O","year":"2004","journal-title":"Pathophysiology"},{"key":"e_1_2_4_107_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0420.1998.tb00880.x","article-title":"Fatty acid use in glaucomatous optic neuropathy treatment","volume":"227","author":"Cellini M","year":"1998","journal-title":"Acta Ophthalmol Scand Suppl"},{"key":"e_1_2_4_108_2","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00417-005-0084-6","article-title":"Protective effects of various antioxidants during ischemia\u2010reperfusion in the rat retina","volume":"244","author":"Dilsiz N","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"e_1_2_4_109_2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/089771502753594936","article-title":"Enhanced survival and regeneration of axotomized retinal ganglion cells by a mixture of herbal extracts","volume":"19","author":"Cheung ZH","year":"2002","journal-title":"J Neurotrauma"},{"key":"e_1_2_4_110_2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000027305","article-title":"The protection of the retina from ischemic injury by the free radical scavenger EGb 761 and zinc in the cat retina","volume":"212","author":"Kim SY","year":"1998","journal-title":"Ophthalmologica"},{"key":"e_1_2_4_111_2","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/4734","article-title":"Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy","volume":"5","author":"Moalem G","year":"1999","journal-title":"Nat Med"},{"key":"e_1_2_4_112_2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0165-5728(00)00240-X","article-title":"Autoimmune T cells retard the loss of function in injured rat optic nerves","volume":"106","author":"Moalem G","year":"2000","journal-title":"J Neuroimmunol"},{"key":"e_1_2_4_113_2","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1096\/fasebj.13.10.1207","article-title":"Differential T cell response in central and peripheral nerve injury: connection with immune privilege","volume":"13","author":"Moalem G","year":"1999","journal-title":"FASEB J"},{"key":"e_1_2_4_114_2","doi-asserted-by":"crossref","first-page":"6421","DOI":"10.1523\/JNEUROSCI.20-17-06421.2000","article-title":"Passive or active immunization with myelin basic protein promotes recovery from spinal cord contusion","volume":"20","author":"Hauben E","year":"2000","journal-title":"J Neurosci"},{"issue":"2","key":"e_1_2_4_115_2","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/112067210101102S01","article-title":"Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches","volume":"11","author":"Schwartz M","year":"2001","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"e_1_2_4_116_2","doi-asserted-by":"crossref","first-page":"S256","DOI":"10.1016\/S0039-6257(01)00208-9","article-title":"Physiological approaches to neuroprotection. Boosting of protective autoimmunity","volume":"45","author":"Schwartz M","year":"2001","journal-title":"Surv Ophthalmol"},{"key":"e_1_2_4_117_2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1167\/iovs.02-0594","article-title":"Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture","volume":"44","author":"Schwartz M","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_118_2","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1073\/pnas.041609498","article-title":"Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: implications for glaucoma","volume":"98","author":"Schori H","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_119_2","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1523\/JNEUROSCI.21-11-03740.2001","article-title":"Protective autoimmunity is a physiological response to CNS trauma","volume":"21","author":"Yoles E","year":"2001","journal-title":"J Neurosci"},{"key":"e_1_2_4_120_2","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.ajo.2006.01.073","article-title":"A rat model for acute rise in intraocular pressure: immune modulation as a therapeutic strategy","volume":"141","author":"Ben Simon GJ","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"e_1_2_4_121_2","doi-asserted-by":"crossref","first-page":"7446","DOI":"10.1073\/pnas.97.13.7446","article-title":"T cell immunity to copolymer 1 confers neuroprotection on the damaged optic nerve: possible therapy for optic neuropathies","volume":"97","author":"Kipnis J","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_122_2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/BF03401714","article-title":"Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia","volume":"3","author":"Botchkina GI","year":"1997","journal-title":"Mol Med"},{"key":"e_1_2_4_123_2","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.STR.25.7.1481","article-title":"Tumor necrosis factor\u2010alpha expression in ischemic neurons","volume":"25","author":"Liu T","year":"1994","journal-title":"Stroke"},{"key":"e_1_2_4_124_2","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.STR.28.6.1233","article-title":"Tumor necrosis factor\u2010alpha. A mediator of focal ischemic brain injury","volume":"28","author":"Barone FC","year":"1997","journal-title":"Stroke"},{"key":"e_1_2_4_125_2","first-page":"1787","article-title":"TNF\u2010alpha and TNF\u2010alpha receptor\u20101 in the retina of normal and glaucomatous eyes","volume":"42","author":"Tezel G","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_2_4_126_2","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.exer.2006.07.008","article-title":"Effect of GLC756, a novel mixed dopamine D1 receptor antagonist and dopamine D2 receptor agonist, on TNF\u2010alpha release in vitro from activated rat mast cells","volume":"83","author":"Laengle UW","year":"2006","journal-title":"Exp Eye Res"},{"key":"e_1_2_4_127_2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1016\/j.exer.2006.07.001","article-title":"GLC756 decreases TNF\u2010alpha via an alpha2 and beta2 adrenoceptor related mechanism","volume":"83","author":"Laengle UW","year":"2006","journal-title":"Exp Eye Res"},{"key":"e_1_2_4_128_2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0092-8674(91)90628-C","article-title":"The trkB tyrosine protein kinase is a receptor for brain\u2010derived neurotrophic factor and neurotrophin\u20103","volume":"66","author":"Klein R","year":"1991","journal-title":"Cell"},{"key":"e_1_2_4_129_2","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1073\/pnas.89.7.3060","article-title":"Mammalian neurotrophin\u20104: structure, chromosomal localization, tissue distribution, and receptor specificity","volume":"89","author":"Ip NY","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"e_1_2_4_130_2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/350678a0","article-title":"High\u2010affinity NGF binding requires coexpression of the trk proto\u2010oncogene and the low\u2010affinity NGF receptor","volume":"350","author":"Hempstead BL","year":"1991","journal-title":"Nature"}],"container-title":["Optometry and Vision Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31817841e5","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1097\/OPX.0b013e31817841e5","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1097\/OPX.0b013e31817841e5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:42:33Z","timestamp":1774932153000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1097\/OPX.0b013e31817841e5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":129,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["10.1097\/OPX.0b013e31817841e5"],"URL":"https:\/\/doi.org\/10.1097\/opx.0b013e31817841e5","archive":["Portico"],"relation":{},"ISSN":["1040-5488","1538-9235"],"issn-type":[{"value":"1040-5488","type":"print"},{"value":"1538-9235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}